Psychiatric drugs explained / David Healy.
Material type: TextPublication details: Edinburgh : Churchill Livingstone, 2009.Edition: 5th edDescription: 344 p. : illISBN:- 9780702029974 (pbk.) :
- 9780702029974 (pbk.) :
- 615.788 HEA
- 615.78 22
- RM315
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Long Loan | TUS: Midlands, Main Library Athlone Nursing Collection | 615.788 HEA (Browse shelf(Opens below)) | 1 | Available | 208689 | ||
Short Loan | TUS: Midlands, Main Library Athlone Nursing Collection | 615.788 HEA (Browse shelf(Opens below)) | 1 | Available | 208688 |
Previous ed.: Edinburgh: Elsevier Churchill Livingston, 2005.
Formerly CIP. Uk
Includes bibliographical references and index.
1. Introduction: Section 1. Management of psychoses:- 2. Antipsychotics--3. Antipsychotic side effects and their management--References--Section 2 --Management of depression:- 4. Antidepressants--5. Side effects of antidepressants--References--Section 3. Management of bipolar disorders:- 6. Management of acute bipolar disorder--7. Mood-stabilisers--References--Section 4. Drugs for children:-8. Drugs for children--References--Section 5. Management of anxiety:- 9. Anxiety disoders--10. Benzodiazepine anxiolytics--11. Anxiolysis and the serotonin system--12. Beta-blockers and anxiety--References--Section 6. Management of sleep disorders and insomnia:- 13. Sleep disorders and insomnia--14. Non-pharmacological management of insomnis--15. Hypnotics--16. Sedatives--References--Section 7: Management of cognitive impairment:- 17. Cognitive enhancement and the dementias--18. Cognitive enhancement and neuroprotection--References--Section 8. Management of sexual difficulties:- 19. The range of sexual difficulties--20. Effects of drugs on aspects of sexual functioning--Appendix 20.1: Male sexual functioning questionnaire--Appendix 20.2: Female sexual functioning questionnaire--References--Section 9. Management of dependence and withdrawal:- 21. Physical dependence type 1--22. Physical dependence type 2--23. Physical dependence type 3--References--Section 10: Consent, abuse and liability:- 24. Consent--25. Pharmacological abuse--26. Liability--References--Section 11: The marketing of tranquility:- 27. The ethical industry--28. Evidence-based psychiatry--29. The marketing of psychiatric disorders--30. From health care to Pharmageddon--References.
This text provides drug names in generic as well as both UK and US tradenames. In addition to a comprehensive review of drug treatment organised by condition, the text also addresses important issues for professionals and their clients concerning consent, liability and the management of side effects and withdrawal.